Preclinical Evidence Toward the Use of Ketamine for Recombinant Tissue-Type Plasminogen Activator-Mediated Thrombolysis Under Anesthesia or Sedation
Stroke - United States
doi 10.1161/strokeaha.111.620468
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)